Division of Cardiology, Baylor College of Medicine, Houston, TX, USA.
Division of Cardiology, Baylor College of Medicine and the Michael E. DeBakey VA Medical Center Houston, Houston, TX, 77030, USA.
Curr Cardiol Rep. 2021 May 7;23(6):69. doi: 10.1007/s11886-021-01501-7.
To identify and address the challenges associated with the care of ACS patients during the coronavirus 2019 pandemic.
The COVID-19 pandemic has had a considerable global impact with over 2.0 million deaths worldwide so far. There has been considerable evidence suggesting that COVID-19 increases the risk of acute coronary syndromes (ACS). We propose characterizing ACS patients into 3 distinct categories to better assist in appropriate triage and management: critically ill patients, non-critically ill ST elevation myocardial infarction (STEMI) patients, and non-critically ill non-ST elevation myocardial infarction (NSTEMI)/unstable angina (UA) patients. We thoroughly review treatments strategies, management considerations, and current consensus statements for the care of COVID-19 patients with ACS. As we continue to gain more experience with management of COVID-19 in ACS patients and as health-care workers and patients continue to get vaccinated, we must continue to adapt our strategies to treat this high-risk group of patients.
确定并解决在 2019 年冠状病毒病大流行期间治疗急性冠脉综合征（ACS）患者所面临的挑战。
COVID-19 大流行已在全球造成相当大的影响，迄今为止，全球已有超过 200 万人死亡。有相当多的证据表明 COVID-19 增加了急性冠状动脉综合征（ACS）的风险。我们建议将 ACS 患者分为 3 个不同类别，以更好地协助适当的分诊和管理：重症患者、非重症 ST 段抬高型心肌梗死（STEMI）患者和非重症非 ST 段抬高型心肌梗死（NSTEMI）/不稳定型心绞痛（UA）患者。我们全面回顾了 COVID-19 合并 ACS 患者的治疗策略、管理注意事项和当前的共识声明。随着我们继续获得更多管理 COVID-19 合并 ACS 患者的经验，以及医护人员和患者继续接种疫苗，我们必须继续调整我们的策略来治疗这一高危患者群体。
